Navigation Links
Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
Date:9/24/2009

SEATTLE and NEW YORK, Sept. 24 /PRNewswire-FirstCall/ -- At its analyst event today, Dendreon Corporation (Nasdaq: DNDN) provided updates on its regulatory and commercialization progress for PROVENGE(R) (sipuleucel-T), the Company's investigational product candidate for men with advanced prostate cancer.

"2009 has been a transformational year for the company as we prepare to commercialize PROVENGE by the middle of next year and make it available to the many men with metastatic castrate-resistant prostate cancer who currently have few appealing treatment options. We are on track to complete the submission of our Biologics License Application (BLA) amendment to the U.S. Food and Drug Administration (FDA) by the middle of November," said Mitchell H. Gold, M.D., president and chief executive officer. "After FDA approval we will implement a deliberate, stepwise launch to ensure the highest quality standards, patient delivery and experience with this completely new approach that could change the way prostate cancer and eventually other cancers are treated."

In addition to this regulatory progress, Dendreon provided the following updates today during its Analyst Day meeting in New York:

Manufacturing and Commercialization Preparation

  • The existing capacity at Dendreon's New Jersey manufacturing facility represents 25 percent of the total future capacity at this facility. After FDA approval, the Company expects to launch PROVENGE from this existing portion of the New Jersey facility in mid-2010 and to continue to make the product available in a gradual stepwise fashion as the Company ramps up to full capacity at this facility.
  • The Company expects to have 48 workstations in production at the New Jersey facility by the
    '/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
2. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
3. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
4. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
5. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
6. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
7. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
8. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
9. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
10. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
11. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... NineSigma , Inc., the leading innovation partner to organizations ... May 14-16, 2014 at the Global Center for Health ... This is the premier industry event for ... open innovation. Participants will learn how world-changing innovation is ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... HOFFMAN ESTATES, Ill., Nov. 10 Life Spine announced ... Invasive Spinal System. The AVATAR MIS ... screws. Combining the novel screw delivery system with ... designed to accommodate evolving surgical approaches, as well as ...
... MedPro Imaging, a premium provider of new and refurbished ... MC Ultrasound, a leading on-site ultrasound provider for high ... area. The acquisition marks yet another milestone in MedPro ... its commitment of providing quality ultrasound imaging solutions. , ...
Cached Medicine Technology:MedPro Imaging Acquires MC Ultrasound 2
(Date:7/10/2014)... (Boston) Emergency Medical Service (EMS) responders felt better ... receiving focused tactical training according to a new study ... This is the first study to specifically examine the ... scene where a shooter has not yet been neutralized ... , Incidents such as the Columbine High School shooting, ...
(Date:7/10/2014)... baby" an infant seemingly cured of HIV that was reported ... infection in The New England Journal of Medicine ... two years of not taking antiretroviral therapy without evidence of ... in the case. , "Certainly, this is a ... staff involved in the child,s care, and the HIV/AIDS research ...
(Date:7/10/2014)... of Huddersfield could help to improve the quality of ... such as butter, mayonnaise, yoghurt and fruit drinks ... for her work. , Katerina gained her MSc degree ... now she has embarked on research for a PhD. ... is investigating the potential of carbohydrates extracted from the ...
(Date:7/10/2014)... men with localized prostate cancer were more likely ... received less effective treatments and survived for shorter ... depressed, a UCLA study has found. , The ... factors such as bias against the mentally ill, ... man,s lack of investment in his general health ...
(Date:7/9/2014)... DC (July 10, 2014) If you think winning is ... for kids think again: Winning along with other mental bonuses ... of which falls into one of 11 big fun factors, ... winning is all important when it comes to the "fun" ... and quantify what goes into this elusive conceptuntil now. , ...
Breaking Medicine News(10 mins):Health News:Active shooter training increases comfort level of emergency responders 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:World interest in research work on the benefits of the Okra plant 2Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3
... Republic International Corporation (NYSE: ORI ) ... of the regular quarterly cash dividend of 17 cents per ... 2009 to shareholders of record on March 4, 2009.The latest ... approved for the second quarter of 2008. The rate ...
... as Asian AffiliateNEW YORK and SINGAPORE, Feb. 26 ... prevention services, has signed an affiliation agreement with ... group based in Singapore and a subsidiary of ... medicine programs throughout Asia. Under the agreement, ParkwayHealth ...
... 274 adults with intellectual disabilities currently receiving funding ... , Washington, DC(February 23, 2009)The Supports Intensity ... for people with intellectual disability based on individual ... tool, unlike adaptive behavior instruments or other measures ...
... the UCSF-Gladstone Institute for Virology and Immunology Center for ... of the next generation of HIV/AIDS researchers and clinician ... in the American Journal for Public Health ... the AJPH website, the program focuses on overcoming challenges ...
... PARK, Ill., Feb. 26 Abbott ( NYSE: ABT ),today ... (AMO). AMO is now a wholly owned subsidiary of ... The acquisition of AMO enhances and strengthens ... leadership position in the large and,growing eye care market. ...
... today announced results for the fourth quarter and year ended December 31, 2008. Highlights from continuing operations for the ... Financial Results, (amounts in millions, except per share amounts), ... Q4 ... ...
Cached Medicine News:Health News:U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia 2Health News:U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia 3Health News:Supports Intensity Scale is effective for identifying needs in people with intellectual disability 2Health News:Effective mentoring critical to HIV/AIDS research efforts 2Health News:Abbott Completes Acquisition of Advanced Medical Optics 2Health News:Carriage Services Announces Fourth Quarter 2008 Results 2Health News:Carriage Services Announces Fourth Quarter 2008 Results 3Health News:Carriage Services Announces Fourth Quarter 2008 Results 4Health News:Carriage Services Announces Fourth Quarter 2008 Results 5Health News:Carriage Services Announces Fourth Quarter 2008 Results 6Health News:Carriage Services Announces Fourth Quarter 2008 Results 7Health News:Carriage Services Announces Fourth Quarter 2008 Results 8Health News:Carriage Services Announces Fourth Quarter 2008 Results 9Health News:Carriage Services Announces Fourth Quarter 2008 Results 10Health News:Carriage Services Announces Fourth Quarter 2008 Results 11Health News:Carriage Services Announces Fourth Quarter 2008 Results 12Health News:Carriage Services Announces Fourth Quarter 2008 Results 13Health News:Carriage Services Announces Fourth Quarter 2008 Results 14Health News:Carriage Services Announces Fourth Quarter 2008 Results 15Health News:Carriage Services Announces Fourth Quarter 2008 Results 16Health News:Carriage Services Announces Fourth Quarter 2008 Results 17
Non-Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Trial Lens Sets....
... disc test (P/N LD15C) include a durable ... instructions. P/N LD15C also includes a Plexiglas ... covers for the test subjects fingers ( ... color discs). Beware that these finger cots ...
Opti-Free Express multi-purpose disinfecting solution lasting comfort No Rub formula provides triple action protection for your contact lenses....
Medicine Products: